Midland Research Group, Inc.

Oakland Park, Florida 33334

0 studies enrolling now · 3 studies all time

What they study most

HIV-1-infection, Human Immunodeficiency Virus

Studies at this site

• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 — Running, not enrolling
• Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1 — Completed
• Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) — Stopped early